Antimicrobial treatment of hospital-acquired pneumonia.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinics in Chest Medicine

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0891-5520(03)00069-2PMID 15802171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia.

  2004cited by this paper
• Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity

  2004cited by this paper
• Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.

  2004cited by this paper
• Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. A randomized trial. Chastre J, Wolff M, Fagon JY, Chevret S et al. JAMA 2003; 290: 2588-98

  2004cited by this paper
• Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

  2003cited by this paper
• Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

  2003cited by this paper
• Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time.

  2003cited by this paper
• Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome*

  2003cited by this paper
• Incidence and outcome of polymicrobial ventilator-associated pneumonia.

  2002cited by this paper
• Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU.

  2002cited by this paper
• Staphylococcus aureus resistant to vancomycin--United States, 2002.

  2002cited by this paper
• Ventilator-associated pneumonia.

  2002cited by this paper
• Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

  2002cited by this paper
• Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa

  2002cited by this paper
• Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets.

  2002cited by this paper
• Antibiotic Resistance in the Intensive Care Unit

  2001cited by this paper
• Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia

  2001cited by this paper
• Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

  2001cited by this paper
• On the importance of sympathovagal balance.

  2001cited by this paper
• Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia

  2000cited by this paper
• Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus.

  2000cited by this paper
• Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

  2000cited by this paper
• Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.

  1999cited by this paper
• Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

  1999cited by this paper
• Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

  1999cited by this paper
• Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups.

  1999cited by this paper
• Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

  1999cited by this paper
• Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

  1998cited by this paper
• Clinical problems posed by multiresistant nonfermenting gram-negative pathogens.

  1998cited by this paper
• Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.

  1998cited by this paper
• The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

  1998cited by this paper
• Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?

  1998cited by this paper
• A computer-assisted management program for antibiotics and other antiinfective agents.

  1998cited by this paper
• Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis.

  1997cited by this paper
• The value of routine microbial investigation in ventilator-associated pneumonia.

  1997cited by this paper
• Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.

  1997cited by this paper
• The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

  1997cited by this paper
• The impact of nosocomial infections on patient outcomes following cardiac surgery.

  1997cited by this paper
• Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system

  1997cited by this paper
• Implementing Antibiotic Practice Guidelines through Computer-Assisted Decision Support: Clinical and Financial Outcomes

  1996cited by this paper
• Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995.

  1996cited by this paper
• Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement

  1996cited by this paper
• Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

  1996cited by this paper
• Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit

  1996cited by this paper
• Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

  1995cited by this paper
• Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia.

  1995cited by this paper
• Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

  1994cited by this paper
• Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group

  1994cited by this paper
• Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

  1993cited by this paper
• Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

  1993cited by this paper
• Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.

  1993cited by this paper
• Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.

  1993cited by this paper
• Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

  1992cited by this paper
• Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Incidence, outcome, and risk factors.

  1992cited by this paper
• Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy

  1992cited by this paper
• Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s.

  1991cited by this paper
• Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. The Endotracheal Tobramycin Study Group

  1990cited by this paper
• Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.

  1990cited by this paper
• Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients.

  1989cited by this paper
• Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia.

  1988cited by this paper
• A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia.

  1983cited by this paper

• Pneumonie im hohen Lebensalter

  2021cites this paper
• Pseudomonas aeruginosa infection in intensive care: Epidemiology, outcomes, and antimicrobial susceptibilities.

  2020cites this paper
• Printed educational materials: effects on professional practice and healthcare outcomes.

  2020cites this paper
• Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model.

  2014cites this paper
• Printed educational materials: effects on professional practice and healthcare outcomes.

  2012cites this paper
• Caracterización de la neumonía adquirida fuera del hospital

  2011cites this paper
• Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients*

  2009cites this paper
• Neumonía adquirida en hospitales. Un problema común que merece mayor atención

  2009cites this paper
• Pathogens in Early-Onset and Late-Onset Intensive Care Unit–Acquired Pneumonia

  2007cites this paper
• Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.

  2007cites this paper
• Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia.

  2006cites this paper
• antibiotics in t HE intEnsivE c arE Unit (ii)

  2005cites this paper
• Pneumonia nosocomial: Actualização terapêutica

  2005cites this paper